[IL-2 post-autologous transplant of hematopoietic stem cells].
Rayon
C
C
Hospital Central, Oviedo.
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation; D003131:Combined Modality Therapy; D003561:Cytarabine / Q000008:administration & dosage; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000008:administration & dosage; D006801:Humans; D015255:Idarubicin / Q000008:administration & dosage; D007376:Interleukin-2 / Q000008:administration & dosage*; D015470:Leukemia, Myeloid, Acute / Q000628:therapy*; D012074:Remission Induction; D014182:Transplantation, Autologous
D007376:Interleukin-2; D003561:Cytarabine; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D015255:Idarubicin